Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Sweden
/
Healthcare
/
Q-linea
QLINEA
Q-linea
Slow Integration And Competition Will Hinder Revenue With Emerging Promise
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 1 Analyst
Published
21 Aug 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
SEK 80.00
37.0% undervalued
intrinsic discount
21 Aug
SEK 50.40
1Y
-98.6%
7D
-4.9%
Loading
1Y
-98.6%
7D
-4.9%
Author's Valuation
SEK 80.0
37.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
SEK 80.0
37.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-1b
612m
2016
2018
2020
2022
2024
2025
2026
2028
Revenue SEK 612.5m
Earnings SEK 53.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
63.59%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.86%
Calculation
SEK 53.31m
Earnings '28
x
25.14x
PE Ratio '28
=
SEK 1.34b
Market Cap '28
SEK 1.34b
Market Cap '28
/
14.13m
No. shares '28
=
SEK 94.89
Share Price '28
SEK 94.89
Share Price '28
Discounted to 2025 @ 5.85% p.a.
=
SEK 80.00
Fair Value '25
